BIO calls for approval of biotech salmon

05/1/2013 | BiofuelsDigest.com

BIO encouraged the FDA to approve AquaBounty Technologies' AquAdvantage biotech salmon, saying that all scientific steps required for regulatory approval have been completed. "This evaluation has been thorough. It is past time to provide a decision and let the market determine whether it supports this innovation that produces healthy food in a sustainable manner by using inland farms to help us meet global protein needs," said David Edwards, BIO's director of animal biotechnology.

View Full Article in:

BiofuelsDigest.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL